Does the Intraoperative Administration of Tranexamic Acid (TXA) Increase the Incidence of Deep Venous Thrombosis in Total Knee Arthroplasty?

Trial Profile

Does the Intraoperative Administration of Tranexamic Acid (TXA) Increase the Incidence of Deep Venous Thrombosis in Total Knee Arthroplasty?

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Tranexamic acid (Primary)
  • Indications Venous thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jan 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.
    • 10 Jan 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.
    • 10 Jan 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top